Song Ruixuan, Executive Chairman of the China Drug Promotion Association, met with Peng Lixuan, Counselor of the Singapore 鈱 Embassy

On the afternoon of December 21, 2020, Song Ruixuan, Executive Chairman of the China Pharmaceutical Innovation Promotion Association (the "China Pharmaceutical Promotion Association"), met with Mr. Peng , Counselor of the Singapore Embassy in China and Deputy Director of the Economic Development Bureau for Greater China, and the two sides exchanged in-depth views on strengthening exchanges between China and Singapore in the biopharmaceutical industry and promoting the establishment of a mutual recognition mechanism between the drug regulatory agencies of the two countries.
President Song welcomedPeng's visit.
Song mentioned that the Chinese government attaches great importance to exchanges and cooperation in the pharmaceutical industry with ASEAN countries represented by Singapore, which will be the main suppliers of home-made new crown vaccines.
As the country with the highest proportion of Chinese in the world, Singapore's open and inclusive business environment, good biomedical ecological environment, strong basic scientific research capabilities and talent training mechanism make Singapore the preferred country for foreign-funded enterprises to enter the Asian and ASEAN markets.
as more and more Chinese pharmaceutical companies set up branches and plants in Singapore, Singapore has great potential to develop into an Asian pharmaceutical innovation research and development center. President
Song said that the Chinese Pharmaceutical Promotion Association is willing to cooperate with the Singapore Embassy and the Economic Development Bureau to give full play to the unique advantages of China and Singapore in the field of medicine under the framework of the Regional Comprehensive Economic Partnership Agreement (RCEP), promote Singapore's preferential policies for investment, build a platform for cooperation and exchange between the Chinese and New Singapore pharmaceutical industries, and help Singapore become an asian pharmaceutical innovation and research and development center.
Pengsaid that the Singapore government has made the biopharmaceutical industry a new engine for the country's economic development, and after many years of development, Singapore has become one of the most dynamic biopharmaceutical centres in Asia.
government attaches great importance to and welcomes Chinese pharmaceutical companies to set up new factories and research and development centers, and has introduced corresponding incentives.
the two sides expressed their willingness to actively promote the mutual recognition mechanism between China and Singapore, accelerate the entry of drugs approved for listing in China into the Singapore market, and promote regional integration of drug regulatory policy systems between China and ASEAN countries.
the meeting deepened cooperation and exchanges between China and New China in the fields of pharmaceutical innovation and research and development, laying a solid foundation for promoting deeper cooperation between the pharmaceutical industry of the two countries in the future.
Mr. Cai Zonglun, Director of the Beijing Office of the Singapore Economic Development Bureau, Feng Qi, Secretary General of the China Drug Promotion Association, Yu Xinxin, Deputy Director of the International Department, and Li Gen, Project Director, participated in the meeting.
Peng , Deputy Director of the Singapore Economic Development Board for Greater China (first from left) Song Ruixuan (centre), Executive Director of the China Drug Promotion Association, Director of the Beijing Office of the Singapore Economic Development Bureau (first from right)